Middle East & Africa Viral Vector Purification Market to 2032

Overview

The Middle East & Africa Viral Vector Purification Market is expected to reach a 35.41 USD Million by 2032 and is projected to grow at a CAGR of 20.20% from 2025 to 2032.

Revenue, 2024 (USD Million)
13.72
Forecast, 2032 (USD Million)
35.41
CAGR, 2024 - 2032
20.20%
Report Coverage
Middle East & Africa

Middle East & Africa Viral Vector Purification Market 2018-2032 USD Million

Middle East & Africa Viral Vector Purification Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 13.72 USD Million
  • Projected Market Size (2032): 35.41 USD Million
  • CAGR (2025-2032): 20.20%

Key Findings of Middle East & Africa Viral Vector Purification Market

  • The Middle East & Africa Viral Vector Purification Market was valued at 13.72 USD Million in 2024.
  • The Middle East & Africa Viral Vector Purification Market is likely to grow at a CAGR of 20.20% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Upstream Processing in Workflow Segment accounted for the largest share of the market with a revenue of 12.23 USD Million
  • The fastest growing segment Chromatography in Purification Technique Segment grew Fastest with a CAGR of 23.26% during the forecast period from 2024 to 2032.

Middle East & Africa Viral Vector Purification Market Scope

Middle East & Africa Viral Vector Purification Market Segmentation & Scope
Disease Indication
  • Other
  • Cancer
  • Veterinary Disease
  • Infectious Diseases
  • Genetic Disorders
Application
  • Antisense & RNAI
  • Vaccinology
  • Cell Therapy
  • Gene Therapy
End User
  • Contract Research Organizations
  • Biotechnology Companies
  • Contract Development And Manufacturing Organization (CDMO)
  • Pharmaceutical Companies
  • Academic/ Research Institutes
By Type
  • Vaccine Virus
  • Retroviral Vectors
  • Other
  • Lentivirus
  • Adenoviral Vectors
  • Adeno-Associated Viral Vectors
Workflow
  • Downstream Processing
  • Upstream Processing
Scale of Operation
  • Commercial
  • Preclinical / Clinical
Delivery Mode
  • Ex Vivo
  • In Vivo
Product & Services
  • Services
  • Products
Purification Technique
  • Two-Phase Extraction Systems
  • Precipitation
  • Ultrafiltration
  • Density-Gradient Ultracentrifugation
  • Chromatography

Middle East & Africa Viral Vector Purification Market Data Coverage Insights

Study Period 2024-2032
Base Year 2020
Unit Revenue in USD Million
Market Value in 2024 13.72 USD Million
Market Value in 2032 35.41 USD Million
CAGR (2025-2032) 20.20%
Historic Data 2016-2023
Market Segments Covered Disease Indication,Application,End User,By Type,Workflow,Scale of Operation,Delivery Mode,Product & Services,Purification Technique

Regional Insights:

  • Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 13.72 USD Million in 2024
    • Key Country: South Africa, leading in terms of revenue with value of 4.82 USD Million in 2024.

Segments and Scope

  • Middle East & Africa Viral Vector Purification Market to 2032, By Disease Indication
    • Genetic Disorders is the largest segment in Middle East & Africa Viral Vector Purification Market to 2032 with a revenue of 7.41 USD Million in the year 2024.
    • Infectious Diseases is the Fastest growing segment in Middle East & Africa Viral Vector Purification Market to 2032 with a Growth rate of 20.84 % in forecast period 2025-2032.
  • Middle East & Africa Viral Vector Purification Market to 2032, By Application
    • Gene Therapy is the largest segment in Middle East & Africa Viral Vector Purification Market to 2032 with a revenue of 7.22 USD Million in the year 2024.
    • Gene Therapy is the Fastest growing segment in Middle East & Africa Viral Vector Purification Market to 2032 with a Growth rate of 22.45 % in forecast period 2025-2032.
  • Middle East & Africa Viral Vector Purification Market to 2032, By End User
    • Academic/ Research Institutes is the largest segment in Middle East & Africa Viral Vector Purification Market to 2032 with a revenue of 6.36 USD Million in the year 2024.
    • Academic/ Research Institutes is the Fastest growing segment in Middle East & Africa Viral Vector Purification Market to 2032 with a Growth rate of 21.27 % in forecast period 2025-2032.
  • Middle East & Africa Viral Vector Purification Market to 2032, By By Type
    • Adeno-Associated Viral Vectors is the largest segment in Middle East & Africa Viral Vector Purification Market to 2032 with a revenue of 7.10 USD Million in the year 2024.
    • Lentivirus is the Fastest growing segment in Middle East & Africa Viral Vector Purification Market to 2032 with a Growth rate of 20.59 % in forecast period 2025-2032.
  • Middle East & Africa Viral Vector Purification Market to 2032, By Workflow
    • Upstream Processing is the largest segment in Middle East & Africa Viral Vector Purification Market to 2032 with a revenue of 12.23 USD Million in the year 2024.
    • Upstream Processing is the Fastest growing segment in Middle East & Africa Viral Vector Purification Market to 2032 with a Growth rate of 20.51 % in forecast period 2025-2032.
  • Middle East & Africa Viral Vector Purification Market to 2032, By Scale of Operation
    • Preclinical / Clinical is the largest segment in Middle East & Africa Viral Vector Purification Market to 2032 with a revenue of 8.43 USD Million in the year 2024.
    • Preclinical / Clinical is the Fastest growing segment in Middle East & Africa Viral Vector Purification Market to 2032 with a Growth rate of 21.80 % in forecast period 2025-2032.
  • Middle East & Africa Viral Vector Purification Market to 2032, By Delivery Mode
    • In Vivo is the largest segment in Middle East & Africa Viral Vector Purification Market to 2032 with a revenue of 9.07 USD Million in the year 2024.
    • In Vivo is the Fastest growing segment in Middle East & Africa Viral Vector Purification Market to 2032 with a Growth rate of 21.50 % in forecast period 2025-2032.
  • Middle East & Africa Viral Vector Purification Market to 2032, By Product & Services
    • Products is the largest segment in Middle East & Africa Viral Vector Purification Market to 2032 with a revenue of 10.60 USD Million in the year 2024.
    • Products is the Fastest growing segment in Middle East & Africa Viral Vector Purification Market to 2032 with a Growth rate of 21.07 % in forecast period 2025-2032.
  • Middle East & Africa Viral Vector Purification Market to 2032, By Purification Technique
    • Chromatography is the largest segment in Middle East & Africa Viral Vector Purification Market to 2032 with a revenue of 6.51 USD Million in the year 2024.
    • Chromatography is the Fastest growing segment in Middle East & Africa Viral Vector Purification Market to 2032 with a Growth rate of 23.26 % in forecast period 2025-2032.

Middle East & Africa Viral Vector Purification Market Company Share Analysis

 
Company Name Company Share Analysis
Merck KGaA
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
FUJIFILM Diosynth Biotechnologies
Cytiva
Middle East & Africa Viral Vector Purification Market Company Share Analysis

Middle East & Africa Viral Vector Purification Market Geographical Sales Distribution, 2018-2032 USD Million

Middle East & Africa Viral Vector Purification Market Geographical Sales Distribution, 2018-2032 USD Million

Middle East & Africa Viral Vector Purification Market Company Profiling

Middle East & Africa Viral Vector Purification Market Company Profiling
Frequently Asked Questions
The Middle East & Africa Viral Vector Purification Market is segmented based on Segmentation Disease Indication,Application,End User,By Type,Workflow,Scale of Operation,Delivery Mode,Product & Services,Purification Technique.
Middle East & Africa Viral Vector Purification Market was valued at USD 13.72(Revenue in USD Million) in 2020.
Middle East & Africa Viral Vector Purification Market is projected to grow at a CAGR of 20.20% during the forecast period of 2024 to 2032.
The Upstream Processing segment is expected to dominate the Middle East & Africa Viral Vector Purification Market, holding a largest market share of 12.23 USD Million in 2024

Middle East & Africa Viral Vector Purification Market Scope

Middle East & Africa Viral Vector Purification Market Segmentation & Scope
Disease Indication
  • Other
  • Cancer
  • Veterinary Disease
  • Infectious Diseases
  • Genetic Disorders
Application
  • Antisense & RNAI
  • Vaccinology
  • Cell Therapy
  • Gene Therapy
End User
  • Contract Research Organizations
  • Biotechnology Companies
  • Contract Development And Manufacturing Organization (CDMO)
  • Pharmaceutical Companies
  • Academic/ Research Institutes
By Type
  • Vaccine Virus
  • Retroviral Vectors
  • Other
  • Lentivirus
  • Adenoviral Vectors
  • Adeno-Associated Viral Vectors
Workflow
  • Downstream Processing
  • Upstream Processing
Scale of Operation
  • Commercial
  • Preclinical / Clinical
Delivery Mode
  • Ex Vivo
  • In Vivo
Product & Services
  • Services
  • Products
Purification Technique
  • Two-Phase Extraction Systems
  • Precipitation
  • Ultrafiltration
  • Density-Gradient Ultracentrifugation
  • Chromatography
Frequently Asked Questions
The Middle East & Africa Viral Vector Purification Market is segmented based on Segmentation Disease Indication,Application,End User,By Type,Workflow,Scale of Operation,Delivery Mode,Product & Services,Purification Technique.
Middle East & Africa Viral Vector Purification Market was valued at USD 13.72(Revenue in USD Million) in 2020.
Middle East & Africa Viral Vector Purification Market is projected to grow at a CAGR of 20.20% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Viral Vector Purification Market for final year is USD 35.41 (USD Million).

Middle East & Africa Viral Vector Purification Market Company Profiling

Middle East & Africa Viral Vector Purification Market Company Profiling
Frequently Asked Questions
The Middle East & Africa Viral Vector Purification Market is segmented based on Segmentation Disease Indication,Application,End User,By Type,Workflow,Scale of Operation,Delivery Mode,Product & Services,Purification Technique.
Middle East & Africa Viral Vector Purification Market was valued at USD 13.72(Revenue in USD Million) in 2020.
Middle East & Africa Viral Vector Purification Market is projected to grow at a CAGR of 20.20% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Viral Vector Purification Market for final year is USD 35.41 (USD Million).

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 8500.00

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.